SARS-CoV-2 structural features may explain limited neutralizing-antibody responses

被引:43
|
作者
Bachmann, Martin F. [1 ,2 ,3 ]
Mohsen, Mona O. [2 ,3 ]
Zha, Lisha [1 ]
Vogel, Monique [1 ]
Speiser, Daniel E. [4 ,5 ]
机构
[1] Anhui Agr Univ, Int Immunol Ctr, Hefei, Peoples R China
[2] Univ Hosp Bern, Dept Rheumatol Immunol & Allergol, Bern, Switzerland
[3] Univ Bern, Dept BioMed Res, Bern, Switzerland
[4] Univ Hosp, Lausanne, Switzerland
[5] Univ Lausanne, Lausanne, Switzerland
基金
瑞士国家科学基金会;
关键词
CORONAVIRUS; IMMUNITY; CELL; ANTIGEN; IMMUNOGENICITY; INFECTION;
D O I
10.1038/s41541-020-00264-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Neutralizing antibody responses of SARS-CoV-2-infected patients may be low and of short duration. We propose here that coronaviruses employ a structural strategy to avoid strong and enduring antibody responses. Other viruses induce optimal and long-lived neutralizing antibody responses, thanks to 20 or more repetitive, rigid antigenic epitopes, spaced by 5-10nm, present on the viral surface. Such arrays of repetitive and highly organized structures are recognized by the immune system as pathogen-associated structural patterns (PASPs), which are characteristic for pathogen surfaces. In contrast, coronaviruses are large particles with long spikes (S protein) embedded in a fluid membrane. Therefore, the neutralizing epitopes (which are on the S protein) are loosely "floating" and widely spaced by an average of about 25nm. Consequently, recruitment of complement is poor and stimulation of B cells remains suboptimal, offering an explanation for the inefficient and short-lived neutralizing antibody responses.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Development of neutralizing antibody responses against SARS-CoV-2 in COVID-19 patients
    Teresa Valenzuela, Maria
    Urquidi, Cinthya
    Rodriguez, Nicolas
    Castillo, Luis
    Fernandez, Jorge
    Ramirez, Eugenio
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (07) : 4334 - 4341
  • [32] Structural basis of nanobodies neutralizing SARS-CoV-2 variants
    Shi, Zhenzhong
    Li, Xiyang
    Wang, Lu
    Sun, Zengchao
    Zhang, Haiwei
    Chen, Xiaochen
    Cui, Qianqian
    Qiao, Huarui
    Lan, Zhongyun
    Zhang, Xin
    Li, Xianheng
    Li, Lingyun
    Xu, Jianfeng
    Gong, Rui
    Fan, Chengpeng
    Geng, Yong
    STRUCTURE, 2022, 30 (05) : 707 - +
  • [33] Neutralizing antibodies do not fully explain SARS-CoV-2 protective immunity
    Sun, Kaiyuan
    Cohen, Cheryl
    NATURE MEDICINE, 2024, : 2741 - 2742
  • [34] Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions
    Gavor, Edem
    Choong, Yeu Khai
    Er, Shi Yin
    Sivaraman, Hariharan
    Sivaraman, J.
    TRENDS IN IMMUNOLOGY, 2020, 41 (11) : 1006 - 1022
  • [35] Characterization of the neutralizing antibody response in SARS-CoV-2 infected individuals
    Mamede, J.
    Ash, M.
    Gambut, S.
    Melani, R.
    Dharan, A.
    Tarhoni, I.
    Fhied, C.
    Goo, Y. Ah
    Campbell, E.
    Al-Harthi, L.
    Kelleher, N.
    Borgia, J.
    Schneider, J.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24
  • [36] SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
    Barnes, Christopher O.
    Jette, Claudia A.
    Abernathy, Morgan E.
    Dam, Kim-Marie A.
    Esswein, Shannon R.
    Gristick, Harry B.
    Malyutin, Andrey G.
    Sharaf, Naima G.
    Huey-Tubman, Kathryn E.
    Lee, Yu E.
    Robbiani, Davide F.
    Nussenzweig, Michel C.
    West, Anthony P., Jr.
    Bjorkman, Pamela J.
    NATURE, 2020, 588 (7839) : 682 - +
  • [37] SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
    Christopher O. Barnes
    Claudia A. Jette
    Morgan E. Abernathy
    Kim-Marie A. Dam
    Shannon R. Esswein
    Harry B. Gristick
    Andrey G. Malyutin
    Naima G. Sharaf
    Kathryn E. Huey-Tubman
    Yu E. Lee
    Davide F. Robbiani
    Michel C. Nussenzweig
    Anthony P. West
    Pamela J. Bjorkman
    Nature, 2020, 588 : 682 - 687
  • [38] Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission
    Kim, Young-Il
    Kim, Se-Mi
    Park, Su-Jin
    Kim, Eun-Ha
    Yu, Kwang-Min
    Chang, Jae-Hyung
    Kim, Eun Ji
    Casel, Mark Anthony B.
    Rollon, Rare
    Jang, Seung-Gyu
    Um, Jihye
    Song, Min-Suk
    Jeong, Hye Won
    Kim, Eung-Gook
    Kim, Yeonjae
    Kim, So Yeon
    Park, Jun-Sun
    Park, Mi Sun
    Kwon, Geun-Yong
    Yeo, Sang Gu
    Lee, Shin-Ae
    Choi, Youn Jung
    Jung, Jae U.
    Choi, Young Ki
    EMERGING MICROBES & INFECTIONS, 2021, 10 (01) : 152 - 160
  • [39] The first Chinese national standards for SARS-CoV-2 neutralizing antibody
    Guan, Lidong
    Yu, Yuanling
    Wu, Xiaohong
    Nie, Jianhui
    Zhang, Jun
    Wang, Zejun
    Li, Na
    Shi, Rui
    Zhao, Hui
    Chen, Hongbo
    Luo, Chunxia
    Hu, Yaling
    Wang, Youchun
    Huang, Weijin
    Xu, Miao
    Hou, Jifeng
    VACCINE, 2021, 39 (28) : 3724 - 3730
  • [40] Recent Developments in SARS-CoV-2 Neutralizing Antibody Detection Methods
    Ndzouboukou, Jo-Lewis Banga
    Zhang, Yan-di
    Fan, Xiong-lin
    CURRENT MEDICAL SCIENCE, 2021, 41 (06) : 1052 - 1064